Melanoma - FOI Response Register

FoI Number
2024-724
Subject
Melanoma
Date Received
21/02/2025
Request and Response
  1. How many patients have been treated in the past 3 months with the following agents for melanoma (any stage) :

 

•           Cobimetinib

•           Dabrafenib

•           Dabrafenib + Trametinib

•           Dacarbazine

•           Denosumab

•           Encorafenib + Binimetinib

•           Ipilimumab monotherapy

•           Ipilimumab + Nivolumab

•           Nivolumab monotherapy

•           Nivolumab + Relatlimab

•           Pembrolizumab 

•           Trametinib

•           Vemurafenib

•           Vemurafenib + Cobimetinib

•           Other active systemic anti-cancer therapy

•           Palliative care only

 Nil to all above options

 

  1. If you do not treat Melanoma patients within your Organisation, which Organisation do you refer your patients to?

Aberdeen Royal Infirmary, if unable to be treated locally